Provides the 2024 ACC/AHA clinical performance and quality measures for the management of adults with valvular and structural heart disease.
New valvular heart disease performance measures may standardize quality assessment; leaves open prospective validation before clinical adoption.
AHA Scientific Statements ◼ performance measures ◼ quality indicators ◼ quality measures ◼ structural heart disease ◼ valvular heart disease *ACC/AHA Joint Committee on Clinical Data Standards liaison.†Society for Cardiovascular Angiography and Interventions representative.‡2020 ACC/AHA Valvular Heart Disease Guideline liaison.
No takes yet. Share an insight, caveat, or question.
Jneid et al. (2024) studied this question. The 2024 ACC/AHA report establishes clinical performance and quality measures for adults with valvular and structural heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: